| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $6.1M | +127.2% |
| SG&A Expense | $4.2M | -21.8% |
| Operating Income | -$14.5M | -80.8% |
| Income Tax | $0 | — |
| Net Income | -$10.5M | -195.3% |
| EPS (Basic) | -$0.98 | +39.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.8M | -73.4% |
| Total Assets | $1.9M | -73.0% |
| Current Liabilities | $1.2M | -66.6% |
| Total Liabilities | $1.2M | -66.6% |
| Stockholders' Equity | $1.6M | -59.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.5M | -24.4% |
| Investing Cash Flow | -$3.0M | — |
| Financing Cash Flow | $7.5M | -28.6% |